Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis

C. Vigen, H. N. Hodis, W. L. Chandler, R. A. Lobo, Wendy J. Mack

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences